Efficacy and safety of a 3-month dosing regimen of degarelix in Japanese patients with prostate cancer: a phase II maintenance-dose-finding study

Por Ozono, Seiichiro, Tsukamoto, Taiji, Naito, Seiji, Ohashi, Yasuo, Ueda, Takeshi, Nishiyama, Tsutomu, Maeda, Hideki, Kusuoka, Hidehito, Akazawa, Rio, Ito, Mototsugu, Akaza, Hideyuki
Publicado no Jpn J Clin Oncol (2017)

Efficacy and safety of 3‐month dosing regimen of degarelix in Japanese subjects with prostate cancer: A phase III study

Por Ozono, Seiichiro, Tsukamoto, Taiji, Naito, Seiji, Horie, Shigeo, Ohashi, Yasuo, Uemura, Hiroji, Yokomizo, Yumiko, Fukasawa, Satoshi, Kusuoka, Hidehito, Akazawa, Rio, Saito, Masako, Akaza, Hideyuki
Publicado no Cancer Sci (2018)

Clinical activity of ASP8273 in Asian patients with non‐small‐cell lung cancer with EGFR activating and T790M mutations

Por Murakami, Haruyasu, Nokihara, Hiroshi, Hayashi, Hidetoshi, Seto, Takashi, Park, Keunchil, Azuma, Koichi, Tsai, Chun‐Ming, Yang, James Chih‐Hsin, Nishio, Makoto, Kim, Sang‐We, Kiura, Katsuyuki, Inoue, Akira, Takeda, Koji, Kang, Jin‐Hyoung, Nakagawa, Tomoki, Takeda, Kentaro, Akazawa, Rio, Kaneko, Yuichiro, Shimazaki, Masashi, Morita, Satoshi, Fukuoka, Masahiro, Nakagawa, Kazuhiko
Publicado no Cancer Sci (2018)